Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Patricia Dignacco"'
Autor:
Jay H. Traverse, Patricia Dignacco, Douglas W. Losordo, Theodore A. Bass, Andrea S Hunt, Duncan J. Stewart, Timothy D. Henry, Gary L. Schaer, Richard A. Schatz, Renew Investigators, Ziangoiong Gu, E. Marc Jolicoeur, Andreas M. Zeiher, Hussein R. Al-Khalidi, David A. Henderson, Adel Nada, F. David Fortuin, Dean J. Kereiakes, Christopher J. White, Candice Junge, Thomas J. Povsic
Publikováno v:
JACC: Cardiovascular Interventions. 9:1576-1585
Objectives This study tested whether intramyocardial (IM) administration of mobilized, purified autologous CD34 + cells would improve total exercise time (TET) and angina frequency in patients with refractory angina. Background IM administration of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d187fd89be9f7ab77098cdc8341e728a
https://doi.org/10.1016/j.jcin.2016.05.003
https://doi.org/10.1016/j.jcin.2016.05.003
Autor:
William H. Sauer, Hussein R. Al-Khalidi, Dirk J. van Veldhuisen, Gordon Davis, Richard Clark, William T. Abraham, Patricia Dignacco, Stephen B. Wilton, Christopher Dufton, Ryan G. Aleong, Benjamin A. Steinberg, Debra Marshall, Michael R. Bristow, Laura L. Emery, Stuart J. Connolly, Michel White, Jonathan P. Piccini, Inder S. Anand, Jeff S. Healey
Publikováno v:
American Heart Journal, 199, 51-58. MOSBY-ELSEVIER
Background Few therapies are available for the safe and effective treatment of atrial fibrillation (AF) in patients with heart failure. Bucindolol is a non-selective beta-blocker with mild vasodilator activity previously found to have accentuated ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d164044278b9a2064489078877018f8
https://research.rug.nl/en/publications/b8f34bcf-6be6-4acc-80b3-4d767404c8c2
https://research.rug.nl/en/publications/b8f34bcf-6be6-4acc-80b3-4d767404c8c2
Autor:
Thomas J, Povsic, Timothy D, Henry, Jay H, Traverse, F David, Fortuin, Gary L, Schaer, Dean J, Kereiakes, Richard A, Schatz, Andreas M, Zeiher, Christopher J, White, Duncan J, Stewart, E Marc, Jolicoeur, Theodore, Bass, David A, Henderson, Patricia, Dignacco, Ziangoiong, Gu, Hussein R, Al-Khalidi, Candice, Junge, Adel, Nada, Andrea S, Hunt, Douglas W, Losordo
Publikováno v:
JACC. Cardiovascular interventions. 9(15)
This study tested whether intramyocardial (IM) administration of mobilized, purified autologous CD34(+) cells would improve total exercise time (TET) and angina frequency in patients with refractory angina.IM administration of autologous CD34(+) cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0e7bc6825ab015d9a9a0c83913a55f69
https://pubmed.ncbi.nlm.nih.gov/27491608
https://pubmed.ncbi.nlm.nih.gov/27491608